High Flow Nasal Cannula (HFNC) therapy is valuable in perinatal care for treating respiratory distress syndrome or supporting patients after extubation.
The clinically reported respiratory benefits are reduction of inspiratory resistance (work of breathing), washout of nasopharyngeal dead space, and provision of a positive airway distending pressure.
